What is the P/E ratio of Velvette International Pharma Products?

The latest standalone P/E ratio of Velvette International Pharma Products as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Velvette International Pharma Products?

The latest standalone P/B ratio of Velvette International Pharma Products as of 01-Jan-1970 is -0.33.

What is the 52-week high and low of Velvette International Pharma Products?

The 52-week high of Velvette International Pharma Products is Rs. 0.00 and the 52-week low is Rs. 0.00.

What is the TTM revenue of Velvette International Pharma Products?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Velvette International Pharma Products is Rs. 0.92 (Cr.).

Velvette International Pharma Products Ltd - Stock Valuation and Financial Performance

Name: Velvette International Pharma Products
Brand: Velvette International Pharma Products

BSE: 524528 | NSE: | Household & Personal Products | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Velvette Intl. Phar

Based on:

Data

M-Cap below 100cr DeciZen not available

Velvette International Pharma Products stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

1.5 Cr.

52-wk low:

52-wk high:

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Velvette Intl. Phar:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'98	Mar'99	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05	TTM
ROCE % ⓘ	1.3%	2.7%	5%	2.1%	-82.9%	-3.9%	-11.6%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	8	5	6.1	5.3	4	5.1	0.9	1
Sales YoY Gr.	-	-37.5%	22.2%	-13.7%	-24.8%	29%	-82%	-
Adj EPS ⓘ	-2.4	-0.8	0.1	0	-27	-0.6	-1.5	-1.5
YoY Gr.	-	NA	NA	-20%	-67675%	NA	NA	-
BVPS (₹) ⓘ	8.4	8.6	9.2	10.4	-15.5	-10.3	-10.9	-9.4
Adj Net Profit ⓘ	-0.9	-0.3	0	0	-10.1	-0.3	-0.8	-1
Cash Flow from Ops. ⓘ	-0.1	-0.3	-0.7	-0.2	-0.2	-0.3	0.1	-
Debt/CF from Ops. ⓘ	-203	-33.6	-16.2	-63	-53.2	-32.8	74.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-28.8%	-44.2%	-82%
Adj EPS ⓘ	NA	NA	-437.7%	NA
BVPSⓘ	NA	-205%	-201.7%	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'98	Mar'99	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05	TTM
Return on Equity % ⓘ	-14.2	-4.7	0.3	0.3	-930.8	7.1	16.8	15.1
Op. Profit Mgn % ⓘ	9.5	17.9	20.8	9.7	-241.7	-3.1	-72.7	16.9
Net Profit Mgn % ⓘ	-11.1	-5.8	0.3	0.3	-254	-5.6	-82.3	-82.5
Debt to Equity ⓘ	3	3.1	3.1	2.8	-1.9	-2.1	-2	-
Working Cap Days ⓘ	0	1,036	787	956	922	448	2,574	0
Cash Conv. Cycle ⓘ	0	301	478	644	544	77	288	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Velvette International Pharma Products Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-1.5	-
TTM Sales (₹ Cr.)	0.9	-
BVPS (₹.) ⓘ	-9.4	-
Reserves (₹ Cr.) ⓘ	-9	-
P/BV ⓘ	-0.33	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	0.64 / 8.25
Market Cap (₹ Cr.)	1.5
Equity (₹ Cr.)	4.9
Face Value (₹)	10
Industry PE ⓘ	55.6

Management X-Ray of Velvette Intl. Phar:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Velvette Intl. Phar

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Velvette Intl. Phar

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'98	Mar'99	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05
Sales	8.02	5.01	6.12	5.28	3.97	5.12	0.92
Operating Expenses ⓘ	7.26	4.11	4.85	4.77	13.57	5.28	1.59
Manufacturing Costs	0.09	0.05	0.05	0.06	0.10	0.11	0.04
Material Costs	3.90	2.35	2.72	2.80	1.91	1.89	0.45
Employee Cost	0.60	0.36	0.39	0.34	0.47	0.54	0.13
Other Costs ⓘ	2.66	1.35	1.69	1.58	11.10	2.74	0.97
Operating Profit ⓘ	0.76	0.89	1.27	0.51	-9.60	-0.16	-0.67
Operating Profit Margin (%)	9.5%	17.9%	20.8%	9.7%	-241.0%	-3.1%	-72.7%
Other Income ⓘ	0.08	0.02	0.04	0.24	0.07	0.04	0.07
Interest ⓘ	1.57	1.03	1.14	0.48	0.43	0.04	0.04
Depreciation ⓘ	0.16	0.18	0.15	0.14	0.12	0.13	0.11
Exceptional Items ⓘ	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-0.89	-0.29	0.02	0.14	-10.09	-0.29	-0.76
Tax ⓘ	0	0	0	0.02	0	0	0
Profit After Tax	-0.89	-0.29	0.02	0.11	-10.09	-0.29	-0.76
PAT Margin (%)	-11.1%	-5.8%	0.4%	2.2%	-253.0%	-5.6%	-82.3%
Adjusted EPS (₹)	-2.4	-0.8	0.1	0.3	-27.0	-0.6	-1.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'98	Mar'99	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05
Equity and Liabilities
Shareholders Fund	6.29	6	6.02	6.13	-3.96	-4.14	-4.90
Share Capital ⓘ	3.73	3.73	3.73	3.73	3.73	4.93	4.93
Reserves ⓘ	2.55	2.26	2.29	2.39	-7.69	-9.08	-9.83
Minority Interest	0	0	0	0	0	0	0
Debt	9.46	9.89	10.70	10.65	10.81	10.88	10.74
Long Term Debt	9.46	9.89	10.70	10.65	10.81	10.88	10.74
Short Term Debt	0	0	0	0	0	0	0
Trade Payables	5.24	2.07	1.43	1.56	1.39	1.68	1.70
Others Liabilities ⓘ	0.09	0.12	0.04	0.15	1.33	0.91	0.84
Total Liabilities ⓘ	21.08	18.08	18.19	18.47	9.57	9.33	8.37
Fixed Assets
Gross Block	3.54	3.54	3.54	3.50	3.56	3.72	3.72
Accumulated Depreciation	1.39	1.57	1.72	1.85	1.97	2.25	2.36
Net Fixed Assetsⓘ	2.14	1.97	1.82	1.65	1.59	1.47	1.35
CWIP ⓘ	0	0	0	0	0	0	0
Investmentsⓘ	0.13	0.13	0.13	0.13	0.13	0.13	0.13
Inventories	0.55	0.07	0.03	0.24	0.72	0.16	0.14
Trade Receivables	10.68	10.71	11.07	11.39	2.50	2.47	2.03
Cash Equivalents	0.17	0.25	0.19	0.26	0.16	0.11	0.11
Others Assetsⓘ	7.41	4.96	4.94	4.80	4.48	4.99	4.61
Total Assets ⓘ	21.08	18.08	18.19	18.47	9.57	9.33	8.37

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'98	Mar'99	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05
Cash Flow From Operating Activity ⓘ	-0.05	-0.29	-0.66	-0.17	-0.20	-0.33	0.14
PBT ⓘ	-0.89	-0.29	0.02	0.14	-10.09	-0.29	-0.76
Adjustment ⓘ	2.14	1.61	1.72	0.91	9.51	0.70	0.68
Changes in Working Capital ⓘ	0.28	-0.59	-1.26	-0.74	0.8	-0.7	0.26
Tax Paid ⓘ	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	-1.34	-0.06	-0.20	0.05	-0.06	2.10	0
Capex	0	0	0	0.17	-0.06	2.10	0
Net Investments	0	0	0	0	0	0	0
Others ⓘ	-1.33	-0.06	-0.20	-0.11	0	0	0
Cash Flow From Financing Activityⓘ	1.25	0.43	0.81	0.18	0.16	-1.83	-0.14
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0
Others ⓘ	1.25	0.43	0.81	0.18	0.16	-1.83	-0.14
Net Cash Flow ⓘ	-0.13	0.08	-0.06	0.07	-0.10	-0.06	0

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'98	Mar'99	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05
Ratios
ROE (%)	-28.48	-9.2	0.66	3.1	N/A	N/A	N/A
ROCE (%)	5.41	5.76	8.51	4.28	N/A	N/A	N/A
Asset Turnover Ratio	0.38	0.26	0.34	0.29	0.28	0.54	0.1
PAT to CFO Conversion(x)	N/A	N/A	-33	-1.55	N/A	N/A	N/A
Working Capital Days
Receivable Days	486	779	649	776	638	177	893
Inventory Days	25	23	3	10	44	31	60
Payable Days	490	567	235	195	280	296	1,373

Velvette International Pharma Products Ltd Stock News

Velvette International Pharma Products Ltd FAQs

What is the share price of Velvette Intl. Phar?

Company share prices are keep on changing according to the market conditions. The closing price of Velvette Intl. Phar on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Velvette Intl. Phar?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Velvette Intl. Phar stood at ₹1.53.